Likewise, celecoxib, but not other selective COX-2 inhibitors, has been reported to induce apoptosis in synovial fibroblasts [34] and to cause antiproliferative effects on colon cancer cells and reduction of tumor growth in vivo [35]. This evidence concerns the gene PTGS2 and malignant colon neoplasm.